Home » Stocks » ATRX

Adhera Therapeutics, Inc. (ATRX)

Stock Price: $0.1200 USD 0.0000 (0.00%)
Updated Mar 5, 2021 3:50 PM EST - Market closed
Market Cap 1.30M
Revenue (ttm) 132,000
Net Income (ttm) -8.89M
Shares Out 10.87M
EPS (ttm) -0.82
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 5
Last Price $0.1200
Previous Close $0.1200
Change ($) 0.0000
Change (%) 0.00%
Day's Open 0.1200
Day's Range 0.0900 - 0.1200
Day's Volume 45,152
52-Week Range 0.02 - 0.15

News

There are no news available yet.

About ATRX

Adhera Therapeutics does not have significant operations. Previously, it was involved in the development and commercialization of drug therapeutics for chronic and acute diseases in the United States. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is headquartered in Wake Forest, North Carolina.

Industry
Biotechnology
CEO
Andrew Albert Kucharchuk
Employees
2
Stock Exchange
OTCMKTS
Ticker Symbol
ATRX
Full Company Profile

Financial Performance

In 2019, ATRX's revenue was $252,000, an increase of 231.58% compared to the previous year's $76,000. Losses were -$11.98 million, -28.51% less than in 2018.

Financial Statements